Valeria Cnossen

General Counsel at GALAPAGOS NV

51 year

Health Technology

Profile

Valeria Cnossen is currently the Executive Vice President & General Counsel at Galapagos NV.
Prior to her current position, she served as the Head-Legal & Compliance at Crucell NV and as the General Counsel-Consumer Health Group at Johnson & Johnson Consumer NV.

Valeria Cnossen active positions

Companies	Position	Start
GALAPAGOS NV	General Counsel	2022-12-31

All active positions of Valeria Cnossen

Former positions of Valeria Cnossen

Companies	Position	End
Johnson & Johnson Consumer NV	Corporate Officer/Principal	-
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Compliance Officer	-

See the detail of Valeria Cnossen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Valeria Cnossen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GALAPAGOS NV	Health Technology

Private companies	2
Crucell NV Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.	Health Technology
Johnson & Johnson Consumer NV